Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Santaolalla, Aida"'
Autor:
Santaolalla A; Translational Oncology & Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College, London, UK., Bax HJ; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Guy's Hospital, London, UK., Chauhan J; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Guy's Hospital, London, UK., Josephs DH; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Guy's Hospital, London, UK.; Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Van Hemelrijck M; Translational Oncology & Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College, London, UK., Karagiannis SN; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Guy's Hospital, London, UK.; Breast Cancer Now Research Unit, School of Cancer & Pharmaceutical Sciences, King's College London, Guy's Cancer Centre, London, UK.
Publikováno v:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2024 Apr; Vol. 54 (4), pp. 297-299. Date of Electronic Publication: 2024 Jan 16.
Autor:
Fox L; Translational Oncology and Urology Research (TOUR), Centre for Cancer, Society and Public Health, King's College London, London, United Kingdom., Santaolalla A; Translational Oncology and Urology Research (TOUR), Centre for Cancer, Society and Public Health, King's College London, London, United Kingdom., Handford J; Translational Oncology and Urology Research (TOUR), Centre for Cancer, Society and Public Health, King's College London, London, United Kingdom., Sullivan R; Global Oncology Group, Centre for Cancer, Society and Public Health, King's College London, London, United Kingdom., Torode J; Global Oncology Group, Centre for Cancer, Society and Public Health, King's College London, London, United Kingdom., Vanderpuye V; National Centre for Radiotherapy, Oncology and Nuclear Medicine, Korle Bu Teaching Hospital, Accra, Ghana., Pramesh CS; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Mula-Hussain L; Sultan Qaboos Comprehensive Cancer Care and Research Centre, Muscat, Oman., AlWaheidi S; Global Oncology Group, Centre for Cancer, Society and Public Health, King's College London, London, United Kingdom., Makaroff LE; World Bladder Cancer Patient Coalition, Brussels, Belgium., Kaur R; Advanced Breast Cancer Global Alliance, Petaling Jaya, Malaysia., Mackay C; World Ovarian Cancer Coalition, Toronto, ON, Canada., Mukherji D; Naef K Basile Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon., Van Hemelrijck M; Translational Oncology and Urology Research (TOUR), Centre for Cancer, Society and Public Health, King's College London, London, United Kingdom.
Publikováno v:
JCO global oncology [JCO Glob Oncol] 2023 Aug; Vol. 9, pp. e2300111.
Autor:
Monroy-Iglesias MJ; Translational Oncology and Urology Research (TOUR), Centre for Cancer, Society, and Public Health, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Crescioli S; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, London SE1 9RT, UK., Beckmann K; Higher Degree by Research, University of South Australia, Adelaide, Australia.; Cancer Epidemiology and Population Health Research Group, University of South Australia, Adelaide, SE, Australia., Le N; Higher Degree by Research, University of South Australia, Adelaide, Australia., Karagiannis SN; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, London SE1 9RT, UK., Van Hemelrijck M; Translational Oncology and Urology Research (TOUR), Centre for Cancer, Society, and Public Health, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Santaolalla A; Translational Oncology and Urology Research (TOUR), Centre for Cancer, Society, and Public Health, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
Publikováno v:
Clinical and experimental immunology [Clin Exp Immunol] 2022 Jul 22; Vol. 209 (1), pp. 46-63.
Autor:
Santaolalla A; School of Cancer & Pharmaceutical Sciences, Translational Oncology and Urology Research, King's College London, London, UK., Garmo H; School of Cancer & Pharmaceutical Sciences, Translational Oncology and Urology Research, King's College London, London, UK.; Regional Oncologic Centre, Uppsala University, Uppsala, Sweden., Grigoriadis A; School of Cancer & Pharmaceutical Sciences, Cancer Bioinformatics, Breast Cancer Now, King's College London, London, UK., Ghuman S; School of Cancer & Pharmaceutical Sciences, Translational Oncology and Urology Research, King's College London, London, UK. sundeep.ghuman@kcl.ac.uk.; Guy's and St Thomas, NHS Foundation Trust, London, UK. sundeep.ghuman@kcl.ac.uk., Hammar N; Department of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Jungner I; Department of Medicine, Clinical Epidemiological Unit, Karolinska Institutet and CALAB Research, Stockholm, Sweden., Walldius G; Unit of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Lambe M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Holmberg L; School of Cancer & Pharmaceutical Sciences, Translational Oncology and Urology Research, King's College London, London, UK., Van Hemelrijck M; School of Cancer & Pharmaceutical Sciences, Translational Oncology and Urology Research, King's College London, London, UK.; Unit of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Publikováno v:
BMC molecular and cell biology [BMC Mol Cell Biol] 2019 Jul 23; Vol. 20 (1), pp. 28. Date of Electronic Publication: 2019 Jul 23.
Autor:
Maria J Monroy-Iglesias, Silvia Crescioli, Kerri Beckmann, Nga Le, Sophia N Karagiannis, Mieke Van Hemelrijck, Aida Santaolalla
Publikováno v:
Clinical and Experimental Immunology. 209:46-63
Increasing evidence has linked the humoral immune response with the development of various cancers. Therefore, there is growing interest in investigating the predictive value of antibodies to assess overall and tissue site-specific cancer risk. Given